These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8100644)

  • 1. Neurochemistry and neuroendocrinology of schizophrenia: a selective review.
    Lieberman JA; Koreen AR
    Schizophr Bull; 1993; 19(2):371-429. PubMed ID: 8100644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.
    Nemeroff CB; Youngblood WW; Manberg PJ; Prange AJ; Kizer JS
    Science; 1983 Sep; 221(4614):972-5. PubMed ID: 6136092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in neurochemical imaging in schizophrenia: an update.
    Vyas NS; Patel NH; Herscovitch P; Puri BK; Lanzenberger R
    Curr Med Chem; 2013; 20(3):351-6. PubMed ID: 23157626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity.
    Lieberman JA; Sheitman BB; Kinon BJ
    Neuropsychopharmacology; 1997 Oct; 17(4):205-29. PubMed ID: 9326746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine regulation of cholangiocarcinoma: A status quo review.
    Sha M; Cao J; Sun HY; Tong Y; Xia Q
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):66-73. PubMed ID: 31152820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotransmitters and hypothalamic hormones in the central nervous system.
    Brownstein M
    Fed Proc; 1977 Jun; 36(7):1960-3. PubMed ID: 16784
    [No Abstract]   [Full Text] [Related]  

  • 7. [Investigation of the dopamine dysregulation hypothesis of schizophrenia with neuroimaging techniques].
    Szekeres G; Pávics L; Janka Z
    Ideggyogy Sz; 2002 Jul; 55(7-8):226-32. PubMed ID: 12201230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the dopamine hypothesis explain schizophrenia?
    Lau CI; Wang HC; Hsu JL; Liu ME
    Rev Neurosci; 2013; 24(4):389-400. PubMed ID: 23843581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurochemistry of human aggression.
    Yanowitch R; Coccaro EF
    Adv Genet; 2011; 75():151-69. PubMed ID: 22078480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides.
    Do Rego JL; Seong JY; Burel D; Leprince J; Luu-The V; Tsutsui K; Tonon MC; Pelletier G; Vaudry H
    Front Neuroendocrinol; 2009 Aug; 30(3):259-301. PubMed ID: 19505496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis.
    Yang AC; Tsai SJ
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New neuroendocrine aspects of depression and anxiety.
    Laakmann G; Hinz A; Neuhauser H
    Clin Neuropharmacol; 1986; 9 Suppl 4():245-7. PubMed ID: 3105879
    [No Abstract]   [Full Text] [Related]  

  • 14. Single-unit activity of hypothalamic arcuate neurons in brain tissue slices. Effects of anterior pituitary hormones, cholecystokinin-octapeptide, and neurotransmitters.
    Pan JT; Kow LM; Pfaff DW
    Neuroendocrinology; 1986; 43(2):189-96. PubMed ID: 2873524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of neuropeptide systems in schizophrenia: human studies.
    Cáceda R; Kinkead B; Nemeroff CB
    Int Rev Neurobiol; 2007; 78():327-76. PubMed ID: 17349866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological challenge strategies: implications for neurochemical mechanisms in affective disorders and treatment approaches.
    Risch SC; Kalin NH; Murphy DL
    J Clin Psychopharmacol; 1981 Jul; 1(4):238-43. PubMed ID: 6117587
    [No Abstract]   [Full Text] [Related]  

  • 17. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems.
    Hirvonen J; Hietala J
    CNS Neurosci Ther; 2011 Apr; 17(2):89-96. PubMed ID: 21199447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychoneuroendocrinology of schizophrenia.
    Marx CE; Lieberman JA
    Psychiatr Clin North Am; 1998 Jun; 21(2):413-34. PubMed ID: 9670234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF; Risch SC
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia.
    du Bois TM; Deng C; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):878-88. PubMed ID: 16005134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.